Published hearing · senate
S.Hrg.118-355
ORIGINS OF COVID-19: AN EXAMINATION OF AVAILABLE EVIDENCE
CHRG-118shrg56048
Publication
No. 355 · 2024-06-18 · GovInfo record 2024-10-15 · OTHERPART
No committee proceeding is explicitly associated with this publication.
Witness lines from the publication
- Gregory D. Koblentz, Ph.D., Associate Professor and Director, Biodefense Graduate Program, George Mason University
- Robert F. Garry, Ph.D., Professor and Associate Dean, School of Medicine, Tulane University
- Steven C. Quay, M.D., Ph.D., Chief Executive Officer, Atossa Therapeutics, Inc., Former Faculty Member, Stanford University School of Medicine
- Richard H. Ebright, Ph.D., Board of Governors Professor of Chemistry and Chemical Biology and Laboratory Director, Waksman Institute of Microbiology, Rutgers University